Health
COVID-19 vaccine | UK reserves 190 million doses from Valneva – Moneycontrol
Valneva said it expects to begin trials of the two-dose vaccine in December and if it is successful for it to become available in the second half of 2021.
Britain has secured access to up to 190 million doses of a potential coronavirus vaccine from French-Austrian biotech company Valneva, AFP reported.
The deal between the UK and Valnevaworth as much as 1.37 billion euros, the firm said on September 14.
It had already been disclosed in July that the British government had reserved 60 million doses of Valneva’s inactivated SARS-CoV-2 vaccine under development.
The firm said it expects to begin trials of the two-dose vaccine in December and if it…
-
Business16 hours ago10 ASX shares to buy after the market selloff
-
General20 hours ago‘We are here for you’: PM to bring help to flood zones
-
Business15 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
General18 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening